In the US, Kefzol (cefazolin systemic) is a member of the drug class first generation cephalosporins and is used to treat Bacterial Endocarditis Prevention, Bacterial Infection, Bone infection, Cholecystitis, Endocarditis, Joint Infection, Kidney Infections, Peritonitis, Pneumonia, Prevention of Perinatal Group B Streptococcal Disease, Septicemia, Skin or Soft Tissue Infection, Surgical Prophylaxis and Urinary Tract Infection.
Ingredient matches for Kefzol
Cefazolin is reported as an ingredient of Kefzol in the following countries:
Cefazolin sodium (a derivative of Cefazolin) is reported as an ingredient of Kefzol in the following countries:
- South Africa
Lidocaine hydrochloride (a derivative of Lidocaine) is reported as an ingredient of Kefzol in the following countries: